Abstract:The transient build-up of DNA supercoiling during the translocation of replication forks threatens genome stability and is controlled by DNA topoisomerases (TOPs). This crucial process has been exploited with TOP poisons for cancer chemotherapy. However, pinpointing cellular determinants of the best clinical response to TOP poisons still remains enigmatic. Here, we present an integrated approach and demonstrate that endogenous and exogenous expression of the oncofetal high-mobility group AT-hook 2 (HMGA2) protein exhibited broad protection against the formation of hydroxyurea-induced DNA breaks in various cancer cells, thus corroborating our previously proposed model in which HMGA2 functions as a replication fork chaperone that forms a protective DNA scaffold at or close to stalled replication forks. We now further demonstrate that high levels of HMGA2 also protected cancer cells against DNA breaks triggered by the clinically important TOP1 poison irinotecan. This protection is most likely due to the recently identified DNA supercoil constraining function of HMGA2 in combination with exclusion of TOP1 from binding to supercoiled substrate DNA. In contrast, low to moderate HMGA2 protein levels surprisingly potentiated the formation of irinotecan-induced genotoxic covalent TOP1-DNA cleavage complexes. Our data from cell-based and several in vitro assays indicate that, mechanistically, this potentiating role involves enhanced drug-target interactions mediated by HMGA2 in ternary complexes with supercoiled DNA. Subtelomeric regions were found to be extraordinarily vulnerable to these genotoxic challenges induced by TOP1 poisoning, pointing at strong DNA topological barriers located at human telomeres. These findings were corroborated by an increased irinotecan sensitivity of patient-derived xenografts of colorectal cancers exhibiting low to moderate HMGA2 levels. Collectively, we uncovered a therapeutically important control mechanism of transient changes in chromosomal DNA topology that ultimately leads to enhanced human subtelomere stability.

Human Smc5/6 recognises transcription-generated positive DNA supercoils

Loop-extruding Smc5/6 organizes transcription-induced positive DNA supercoils

Topoisomerase-modulated genome-wide DNA supercoiling domains colocalize with nuclear compartments and regulate human gene expression

Spatial organization of supercoil dynamics during DNA replication

The Smc5/6 complex counteracts R-loop formation at highly transcribed genes in cooperation with RNase H2

SMC complexes: from DNA to chromosomes

The SMC5/6 complex: folding chromosomes back into shape when genomes take a break

Transcription-driven DNA supercoiling counteracts H-NS-mediated gene silencing in bacterial chromatin

Transcription-mediated supercoiling regulates genome folding and loop formation

DNA tension-modulated translocation and loop extrusion by SMC complexes revealed by molecular dynamics simulations

Innovative Tools for DNA Topology Probing in Human Cells Reveal a Build-Up of Positive Supercoils Following Replication Stress at Telomeres and at the FRA3B Fragile Site

Genome folding through loop extrusion by SMC complexes

Molecular dynamics simulations of human cohesin subunits identify DNA binding sites and their potential roles in DNA loop extrusion

Synergy of topoisomerase and structural-maintenance-of-chromosomes proteins creates a universal pathway to simplify genome topology

Transcription shapes DNA replication initiation to preserve genome integrity

Properties of the SMC protein related to its interaction with DNA

The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity

SMC complex unidirectionally translocates DNA by coupling segment capture with an asymmetric kleisin path

Transcription-induced supercoiling as the driving force of chromatin loop extrusion during formation of TADs in interphase chromosomes

The non-canonical SMC protein SmcHD1 antagonises TAD formation and compartmentalisation on the inactive X chromosome

Superhelical DNA as a preferential binding target of 14-3-3γ protein